About
Erik Kinnman is a Swedish life-science executive and physician specializing in neurology and pain management. He is CEO of Vivesto and previously served as CEO of Abliva and Sprint Bioscience, with earlier senior roles at AstraZeneca and Sobi. He is also an associate professor at Karolinska Institutet and has worked in investor-relations and financial-analysis roles.
Areas of interest
biotechoncologydrug developmentneurologypain managementrare diseaseslife sciences